OVERVIEW

A 3D Learning Experience - Optimizing Cancer Immunotherapy: Treatment Strategies for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck is organized by Med Learning Group and will be held from Nov 28, 2018 - Nov 28, 2019.

Target Audience:
This activity is designed to meet the educational needs of oncologists, oncology nurses and other healthcare professional involved in the management of patients with advanced SCCHN.

Program Overview:
This case-based online activity will cover the management of patients with advanced SCCHN.

Accreditation Statement:
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity is planned and produced in accordance with ACCME Essentials.

Credit Designation Statement:
Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.

Nursing Credit Information:
Purpose: This program would be beneficial for nurses involved in the long-term treatment and management of patients with advanced SCCHN.
CNE Credits: 1.0 ANCC Contact Hour(s)

Learning Objectives:
Upon the completion of this program, attendees should be able to:
• Describe the dysregulation of the immune system that supports the development of SCCHN
• Review the mechanisms of action of immuno-oncology therapies in patients with recurrent and metastatic SCCHN
• Discuss clinical trial-derived efficacy and safety data for immuno-oncology agents for use in patients with recurrent or metastatic SCCHN
• Explain how to recognize and manage immune checkpoint inhibitor-associated immune-related adverse events in patients with SCCHN.